Dalteparin
Dalteparin
Dalteparin (/dælˈtɛpərɪn/) is a type of anticoagulant medication that is used to prevent and treat blood clots. It is a form of heparin, specifically a low molecular weight heparin (LMWH).
Etymology
The term "Dalteparin" is derived from the name of the pharmaceutical company that first developed it, Pharmacia & Upjohn, and the type of drug it is, a heparin.
Usage
Dalteparin is used to prevent deep vein thrombosis (DVT), which can lead to pulmonary embolism (PE) in patients who are undergoing certain types of surgery or who are at risk due to prolonged bed rest. It is also used to treat existing DVT and PE, and to prevent complications of angina and myocardial infarction (heart attack).
Administration
Dalteparin is administered by subcutaneous injection, usually once or twice daily. The dosage is determined by the patient's weight and the specific condition being treated.
Side Effects
Common side effects of Dalteparin include bleeding, bruising at the injection site, and mild irritation. Serious side effects can include severe bleeding, allergic reactions, and thrombocytopenia (low platelet count).
Related Terms
- Anticoagulant
- Heparin
- Deep Vein Thrombosis
- Pulmonary Embolism
- Angina
- Myocardial Infarction
- Subcutaneous Injection
- Thrombocytopenia
External links
- Medical encyclopedia article on Dalteparin
- Wikipedia's article - Dalteparin
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski